Collaboration Details

Print  Close

Title of Collaborative Activity:

NIDA Consultative Assistance to the FDA Regarding Domestic Scheduling of New Medications

Description of Collaborative Activity:

Subsequent to the filing of a New Drug Application by a pharmaceutical company, the FDA prepares an “8-factor analysis” of abuse liability and prepares a draft scheduling recommendation. NIDA reviews the draft documents and provides advice regarding potential revisions.

Type of Collaborative Activity:

Select Type of Collaborative Activity

Year the Collaborative Activity Originated:


NIH Participating Institutes/Centers/Office of the Director:


HHS Agency Collaborators on this Activity: